2018
DOI: 10.3390/polym10080918
|View full text |Cite
|
Sign up to set email alerts
|

Composite Biopolymer-Based Wafer Dressings Loaded with Microbial Biosurfactants for Potential Application in Chronic Wounds

Abstract: In this study two bioactive polysaccharide polymers kappa-carrageenan (CARR) and sodium alginate (SA) incorporated with microbial biosurfactants (BSs) were formulated as medicated wafer dressings for potential application in chronic wounds. Wafers were loaded with BSs at concentrations of 0.1% and 0.2% rhamnolipids (RL) and 0.1% and 5% sophorolipids (SL) and were functionally characterized using scanning electron microscopy (SEM), texture analysis (mechanical strength and in vitro wound adhesion), attenuated t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
25
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(27 citation statements)
references
References 43 publications
1
25
0
Order By: Relevance
“…diabetic foot ulcers (DFUs) due to their biocompatible, adhesive, antibacterial and hemostatic properties. 112,114,116,117 The purpose of the study proposed by Akiyode and Boateng 112 was to investigate two bioactive polysaccharide polymers kappa-carrageenan (CARR) and sodium alginate (SA) incorporated with microbial biosurfactants (BSs) as medicated wafer dressings for potential application in chronic wounds. Wafers were loaded with BSs at concentrations of 0.1% and 0.2% rhamnolipids (RL) and 0.1% and 5% sophorolipids (SL).…”
Section: Mucoadhesive Drug Delivery Systemsmentioning
confidence: 99%
“…diabetic foot ulcers (DFUs) due to their biocompatible, adhesive, antibacterial and hemostatic properties. 112,114,116,117 The purpose of the study proposed by Akiyode and Boateng 112 was to investigate two bioactive polysaccharide polymers kappa-carrageenan (CARR) and sodium alginate (SA) incorporated with microbial biosurfactants (BSs) as medicated wafer dressings for potential application in chronic wounds. Wafers were loaded with BSs at concentrations of 0.1% and 0.2% rhamnolipids (RL) and 0.1% and 5% sophorolipids (SL).…”
Section: Mucoadhesive Drug Delivery Systemsmentioning
confidence: 99%
“…Similarly, the ability to control the water loss at an ideal rate is also important for wound dressings [40]. Therefore, the W R of various BC/AgNW dressings was estimated (Fig.…”
Section: Morphology Structure and Physiochemical Propertiesmentioning
confidence: 99%
“…SWF was prepared as documented earlier. [42][43][44] The pH was adjusted to prepare SWF with various pH (3 to 9). Around 5 lL of this SWF was dropped on the test pad of the device and the color change observed.…”
Section: In Vitro Testing Of Detec ò Ph Performancementioning
confidence: 99%